1030769-75-5
1030769-75-5
Chemical Structure
SRI 37892
- CAS No.: 1030769-75-5
- Formula:C26H19N5O2S
- Molecular Weight:465.53
IUPAC Name: 4-(1H-benzo[d]imidazol-1-yl)-N-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)thiazol-2-yl)benzamide
InChIKey: DXSMYUKZPWJQFM-UHFFFAOYSA-N
SMILES: O=C(NC1=NC(C2=CC3=C(NC(CC3)=O)C=C2)=CS1)C4=CC=C(N5C6=CC=CC=C6N=C5)C=C4
Biological Activity: SRI 37892 is a small molecule compound inhibitor of Frizzled protein 7 (Fzd7) with inhibitory activity against cancer cell proliferation (IC50=2μM). SRI 37892 significantly blocks Wnt/Fzd7 signaling. SRI 3789 can be used in the research of developing cancer therapeutic agents [1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
SRI 37892 | 99.28% | SRI 37892 is a small molecule compound inhibitor of Frizzled protein 7 (Fzd7) with inhibitory activity against cancer cell proliferation (IC50=2μM). SRI 37892 significantly blocks Wnt/Fzd7 signaling. SRI 3789 can be used in the research of developing cancer therapeutic agents . | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
